Glassman Wealth Services’s Audentes Therapeutics, Inc BOLD Stock Holding History

Glassman Wealth Services’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1	Closed	–	–	1761
2019 Q4	$0	Buy	+1	New	+$38	﹤0.01%	1640
2019 Q3	–	Sell	-5	Closed	–	–	1543
2019 Q2	$0	Buy	+5	New	+$192	﹤0.01%	1522

Glassman Wealth Services's BOLD Position: Q1 2020 in Review

Glassman Wealth Services sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 1 share.

Glassman Wealth Services first reported a position in BOLD in Q2 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Glassman Wealth Services reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Glassman Wealth Services sold 1 Audentes Therapeutics, Inc share in Q1 2020.
Glassman Wealth Services first reported a position in Audentes Therapeutics, Inc in Q2 2019 and held it in 2 quarters.
Glassman Wealth Services's Audentes Therapeutics, Inc position peaked at $0 in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Glassman Wealth Services's 13F filing for Q1 2020, filed 12 May 2020.